Cramer Rosenthal Mcglynn LLC purchased a new stake in MetLife, Inc. (NYSE:MET) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 314,130 shares of the financial services provider’s stock, valued at approximately $16,319,000.
Other large investors also recently made changes to their positions in the company. Aviance Capital Management LLC grew its holdings in shares of MetLife by 4.6% during the first quarter. Aviance Capital Management LLC now owns 9,389 shares of the financial services provider’s stock worth $496,000 after purchasing an additional 416 shares during the last quarter. Aldebaran Financial Inc. grew its holdings in shares of MetLife by 1.2% during the first quarter. Aldebaran Financial Inc. now owns 34,321 shares of the financial services provider’s stock worth $1,813,000 after purchasing an additional 400 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in shares of MetLife by 10.4% during the first quarter. Nomura Asset Management Co. Ltd. now owns 327,626 shares of the financial services provider’s stock worth $17,305,000 after purchasing an additional 30,969 shares during the last quarter. Park National Corp OH grew its holdings in shares of MetLife by 2.5% during the second quarter. Park National Corp OH now owns 6,445 shares of the financial services provider’s stock worth $354,000 after purchasing an additional 155 shares during the last quarter. Finally, Trust Co lifted its stake in shares of MetLife by 13.1% during the first quarter. Trust Co now owns 36,154 shares of the financial services provider’s stock valued at $1,909,000 after acquiring an additional 4,175 shares during the period. Hedge funds and other institutional investors own 76.37% of the company’s stock.
In other MetLife news, insider Christopher G. Townsend sold 55,712 shares of the stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the sale, the insider now directly owns 25,181 shares in the company, valued at $1,367,076.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the sale, the insider now owns 49,660 shares of the company’s stock, valued at $2,711,436. The disclosure for this sale can be found here. 0.32% of the stock is owned by corporate insiders.
MetLife, Inc. (NYSE:MET) traded down $0.58 during trading hours on Wednesday, reaching $53.04. The company’s stock had a trading volume of 4,131,200 shares, compared to its average volume of 5,738,007. MetLife, Inc. has a 1 year low of $44.26 and a 1 year high of $55.91. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $56,424.27, a price-to-earnings ratio of 10.31, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49.
MetLife (NYSE:MET) last released its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.19. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. During the same quarter in the prior year, the firm posted $1.28 earnings per share. The company’s quarterly revenue was up 1.7% on a year-over-year basis. sell-side analysts expect that MetLife, Inc. will post 4.43 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be issued a $0.40 dividend. The ex-dividend date is Friday, November 3rd. This represents a $1.60 annualized dividend and a dividend yield of 3.02%. MetLife’s dividend payout ratio (DPR) is currently -320.00%.
ILLEGAL ACTIVITY NOTICE: “Cramer Rosenthal Mcglynn LLC Purchases Shares of 314,130 MetLife, Inc. (MET)” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.chaffeybreeze.com/2017/12/06/cramer-rosenthal-mcglynn-llc-purchases-shares-of-314130-metlife-inc-met.html.
MetLife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.